A Study of How [14C]-BGB-16673 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Participants
Clinical trial NCT06776679 · COMPLETED
Trial details
- NCT number
- NCT06776679
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-24
- Primary completion
- 2025-03-27
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.